Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13767
Abstract: Human fibroblast growth factor 19 (FGF19, or FGF15 in rodents) plays a central role in controlling bile acid (BA) synthesis through a negative feedback mechanism. This process involves a postprandial crosstalk between the BA‐activated ileal… read more here.
Keywords: fgf19 fgfr4; cholestatic metabolic; fgf19; targeting fgf19 ... See more keywords